GlassScriptPhysician profile
Khadeeja Tarique
NPI 1144904525
$4,125.70
in general payments reported to CMS, 2019-2025
10 companies · $3,684 in 2025
The $3,684 reported for 2025 was more than what 95% of Podiatrist providers received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $212 · 2024: $229 · 2025: $3,684.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,509 · Travel and Lodging: $617.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,508.80 |
| Travel and Lodging | $616.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $2,587.31 | 2023-2025 | Ortholoc 2 Lapifuse, Hoffmann, Infinity Adaptis |
| Trimed, INC. | $1,116.88 | 2024-2025 | |
| Axogen | $126.26 | 2025 | |
| Treace Medical Concepts, INC. | $81.90 | 2024-2025 | |
| Fusion Orthopedics USA, LLC | $64.34 | 2025 | |
| Medinc of Texas | $43.01 | 2025 | |
| Globus Medical, INC. | $37.89 | 2025 | Anthem |
| Paratek Pharmaceuticals, INC. | $33.23 | 2025 | Nuzyra |
| Biocomposites INC | $20.44 | 2025 | Stimulan |
| Paragon 28, INC. | $14.44 | 2023 | Gorilla |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Khadeeja Tarique listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.